Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

Among patients who had undergone curative surgery for primary colorectal cancer, the screening methods of computed tomography and carcinoembryonic antigen each provided an improved rate of surgical ...

Baseline ctDNA negativity or on-treatment clearance in anal squamous cell carcinoma correlated with 100% one-year overall survival and no local recurrence, whereas post-treatment positivity predicted ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Pancreatic and colorectal cancers are two of the most concerning cancers. Both are notoriously difficult to detect in their early stages, primarily due to the lack of specific early symptoms and their ...

Low-dose aspirin may slash colorectal cancer recurrence risk by 55%, according to a recent trial. Image credit: soleg/Getty Images The National Cancer Institute predicts that colorectal cancers will ...

Berberine significantly reduced adenoma recurrence and colorectal neoplasm occurrence in a 6-year follow-up study of nearly 800 patients post-polypectomy. The study found that berberine's ...

Safety and Efficacy Study of Ablative Radiation Therapy for Large Liver Metastases Invading Into the Inferior Vena Cava and Heart Patients with CRC who develop locoregional recurrence exhibit a ...

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, ...